Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sacubitril valsartan vs amlodipine in insulin resistance among type 2 diabetes with hypertension
ChiCTR2400088532Phase 4Not yet recruiting
- Sponsor
- Chongqing Armed Police Hospital
- Start
- Aug 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of sacubitril + valsartan in type 2 diabetes mellitus (T2DM) and essential hypertension (2 arms), sponsored by Chongqing Armed Police Hospital. Primary endpoints: HOMA-IR and HbA1c. Planned start Aug 2024; status: not yet recruiting.
02
Drugs
sacubitril + valsartan
03
Conditions
type 2 diabetes mellitus (T2DM)essential hypertension
Beyond the preview
Go deeper on ChiCTR2400088532.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400088532.